Thomas Guiel
Förmögenhet: 10 250 $ per 2026-08-31
Förmögenhet: 10 250 $ per 2026-08-31
Thomas G.
Guiel worked as Principal at Invitrogen Corp., Vice President-Operations at CapForce, Inc., Chief Operating Officer & Executive Vice President at OncoPlex Diagnostics, Inc. from 2013 to 2018, and Chief Operating Officer at Oxford BioDynamics Plc.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
OXFORD BIODYNAMICS PLC 0,05 % | 2025-11-10 | 6 288 146 ( 0,05 % ) | 10 250 $ | 2026-08-31 |
| Företag | Position | Slut |
|---|---|---|
OncoPlex Diagnostics, Inc.
OncoPlex Diagnostics, Inc. Medical/Nursing ServicesHealth Services Operates a cancer diagnostics laboratory | Verksamhetschef | 2018-01-01 |
| OXFORD BIODYNAMICS PLC | Verksamhetschef | - |
| CAPFORCE INC. | Verksamhetschef | - |
Invitrogen Corp.
Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and sells life science research kits and provides research services | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
| Privata företag | 4 |
|---|---|
Invitrogen Corp.
Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and sells life science research kits and provides research services | Electronic Technology |
OpGen, Inc.
OpGen, Inc. Miscellaneous Commercial ServicesCommercial Services Develops technologies against life-threatening, antibiotic-resistant infections using molecular diagnostics and bioinformatics | Commercial Services |
OncoPlex Diagnostics, Inc.
OncoPlex Diagnostics, Inc. Medical/Nursing ServicesHealth Services Operates a cancer diagnostics laboratory | Health Services |
Oxford BioDynamics Plc
Oxford BioDynamics Plc BiotechnologyHealth Technology Discovers and develops novel biomarkers | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån